Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Pacritinib
Trade Name
Synonyms SB1518|SB-1518|SB 1518
Drug Descriptions

Pacritinib (SB1518) is an inhibitor of JAK2 and FLT3, with activity against JAK2 V617F and FLT3 ITD, which potentially increases tumor cell apoptosis, induces cell cycle arrest, and decreases tumor growth (PMID: 22829080, PMID: 21691275).

DrugClasses FLT3 Inhibitor 55 JAK2 Inhibitor - ATP competitive 14
CAS Registry Number 937272-79-2
NCIT ID C78837

Filtering

  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"

Sorting

  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Cytarabine + Daunorubicin + Pacritinib Cytarabine Daunorubicin Pacritinib 0 1
Cytarabine + Pacritinib Cytarabine Pacritinib 0 1
Decitabine + Pacritinib Decitabine Pacritinib 0 3
Erlotinib + Pacritinib Erlotinib Pacritinib 0 1
Ibrutinib + Pacritinib Ibrutinib Pacritinib 0 1
Pacritinib Pacritinib 3 6


Additional content available in CKB BOOST